CALL FOR PARTICIPANTS: Meeting in Annecy, France, 3-4 November 2015

The GFBR will hold a two-day meeting at the Fondation Mérieux, France, on 3-4 November 2015 on the theme of: “Emerging epidemic infections and experimental medical treatments.” This will be the first full GFBR meeting since 2008 and follows the re-launch of the Forum in June 2014 in Mexico.

Following the Ebola outbreak in West Africa last year, renewed attention has been given to ethical issues that arise when research is undertaken during and after disease epidemics, particularly when these occur in low-and-middle-income countries. Outbreaks of MERS-coronavirus, Severe Acute Respiratory Syndrome (SARS) and the H5N1 avian influenza virus in recent years have all involved
complex ethical challenges for the researchers involved in studying the diseases, healthcare workers on the ground, charities, governments, policy-makers and academics. The GFBR meeting will seek to identify and understand the valuable lessons to be learned for the global bioethics and research community in how to anticipate and address these issues in future outbreaks.

Who can attend the GFBR meeting?
There will be a competitive selection process. Up to 80 participants will be selected from the eligible
applicants who submit an application to attend by the deadline. We are seeking broad geographical
representation, a mix of disciplinary expertise including researchers, clinicians, healthcare workers,
bioethicists, policy-makers, health system functionaries, lawyers, and a combination of people who are
early in their careers and leaders in their fields.

To submit an application to attend, please provide the following information in Microsoft Word or pdf
format, in English, by Monday 29 June 2015:

 Short letter of intent not exceeding one page, outlining:
o Why you would like to participate in the GFBR meeting;
o What you can contribute to the meeting. Please note we are looking for people who have an
interest in or experience of working on emerging epidemic infections and experimental
medical treatments.

 Name, institution and contact information
 Short CV (1-2 pages)
 Contact information and email addresses of two references
 Whether you require funding to cover travel and accommodation costs, or you are self-funding.
o Please note that funding will be prioritised for applicants from low- and middle-income
countries. Applicants from other countries are welcome to apply if they can self-fund their
Awards: Decision Making and Eligibility for Funding
Successful applicants from low-and middle-income countries who require full funding will receive an
award to cover:
 return travel to the meeting (economy airfare and standard ground transportation costs); and
 accommodation (2 or 3 nights maximum, including meals).
Participants will be expected to meet all other costs.
The GFBR Planning Committee will select successful candidates (both self-funded and those applying for
funded places). The selection committee will consider the following factors:
 Country of origin. We would like to ensure a representative distribution of participants from
different regions;
 Background/current area of expertise. We would like to seek representation from many
different disciplines relating to the theme of the meeting;
 Experience of ethical issues related to emerging epidemic infections and experimental medical
 Reasons for attending the meeting. We hope to attract participants who will be able to actively
contribute to the meeting.
Please email your application to Applications received after the deadline of 29
June 2015 will not be considered.
Applicants will be informed of the decision by the planning committee by 24 July 2015. The decision of
the committee will be final.
Support for the GFBR
The GFBR is sponsored by a range of international funders. The Wellcome Trust, the National Institutes
of Health, the UK Medical Research Council and the Bill and Melinda Gates Foundation are providing
funding for this meeting. The Fondation Mérieux is generously providing the venue for this meeting.
Members of the Planning Committee for this upcoming meeting are: Philippe Calain, MSF; François
Hirsch, Inserm; Nancy Kass, Johns Hopkins University; José Lapa e Silva, Universidad Federal do Rio de
Janeiro; Katherine Littler, Wellcome Trust; Christophe Longuet, Fondation Mérieux; Barbara Sina, NIH;
Paul Tambyah, National University of Singapore; Aissatou Toure, Pasteur Institute Dhakar; Ross Upshur,
University of Toronto; Douglas Wassenaar, University of KwaZulu-Natal; Aminu Yakubu, Federal
Ministry of Health Nigeria.
Members of the GFBR Interim Steering Committee are: Elizabeth Bukusi, Kenya; Anant Bhan, India; Yali
Cong, China; Patricia J Garcia, Peru; Katherine Littler, UK; Florencia Luna, Argentina; Joseph Millum,
USA; Michael Parker, UK; Frances Rawle, UK; Barbara Sina, USA; Douglas Wassenaar, South Africa.